Back to Agenda
Session 10: DIAmond Session: The Safety Pulse: Executive Insights from Global Chief Safety Officers on Maintaining Best-in-Class PV Organizations
Session Chair(s)
Jamie Wilkins, PharmD
Head, Risk Management Center of Excellence
Pfizer Inc, United States
This fireside chat brings Chief Safety Officers/Heads of Safety from companies of varying sizes to explore the most pressing issues facing pharmacovigilance today. Topics include the future of PV, workforce development and organizational structure, empathetic leadership, the role of AI, and the impact of evolving global regulatory requirements. Attendees will gain firsthand insights into how top safety leaders are navigating change and shaping the future of drug safety.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify current key challenges and opportunities facing global PV organizations
- Contrast approaches for pharmacovigilance leadership best-practices in companies of various sizes
- Describe advice for developing and maintaining best-in-class pharmacovigilance organizations
Speaker(s)
Speaker
Felix Arellano, MD, PhD, FISPE
Hoffmann-La Roche Limited, Switzerland
Global Head Safety Risk Management
Speaker
Mariette Boerstoel-Streefland, MD, MBA, MS
Bristol Myers Squibb, United States
Senior Vice President, Patient Safety Officer
Speaker
Andrea Best, DO, MPH
Gilead Sciences, United States
Vice President and Head of Patient Safety
Speaker
Representative Invited
Moderna, United States
Speaker
Jeremy Jokinen, PhD, MS
Argenx, United States
Vice President and Head Global Patient Safety
Have an account?